Amivantamab in Adenoid Cystic Carcinoma

Clinical trial NCT05074940 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05074940
Sponsor: Trisha Wise-Draper
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Salivary Gland Cancer

Start date: 2022-08-05
Primary completion: 2026-03-02
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.